Prime Health Guide
Home Health A-Z Conditions Symptoms Treatments Wellness About Contact
Home / Institutes & Departments / Neurological Institute / Departments & Centers / Mellen Center for Multiple Sclerosis / Multiple Sclerosis Approaches / Ocrelizumab

Ocrelizumab

  • Appointments 866.588.2264
  • Appointments & Locations
  • Request an Appointment
Neurological Institute

Departments & Centers

  • Mellen Center for Multiple Sclerosis
    • Multiple Sclerosis Approaches
      • Adult-onset Anti-NMDA Receptor Encephalitis
      • Approaches to Diagnosis, Treatment and Management of Optic Neuritis
      • Augmenting MS Management with a Comprehensive Approach to Wellness and Comorbidity
      • Behavioral Management of Anxiety and Depression in Multiple Sclerosis
      • Care of the Transgendered Individual
      • Considerations for the Administration of IVIG in MS Patients
      • COVID-19: Considerations for Multiple Sclerosis Patients
      • Diagnosis and Management of Autoimmune Encephalitis
      • Disability Benefits in Multiple Sclerosis
      • Disease-Modifying Therapy Discontinuation in Multiple Sclerosis
      • DMT Use in Progressive MS
      • Eculizumab (Soliris) for Neuromyelitis Optica Spectrum Disorder
      • Falls & Fall Prevention in Multiple Sclerosis
      • Fatigue in the Context of MS
      • Follow-on Disease Modifying Therapies
      • Identifying and Managing Cognitive Disorders in Multiple Sclerosis
      • Inebilizumab (Uplizna) for Neuromyelitis Optica Spectrum Disorder
      • Lemtrada (alemtuzumab)
      • Management of Bladder Dysfunction in Multiple Sclerosis
      • Management of Menopause and Female Sexual Dysfunction In Multiple Sclerosis
      • Management of Multiple Sclerosis During Pregnancy
      • Multiple Sclerosis & Disability
      • Myelin Oligodendrocyte Antibody Disease
      • Neurofilament Light Chain
      • Neuromyelitis Optica Spectrum Disorders
      • Neuropsychological Assessment in Multiple Sclerosis and CNS Autoimmune Disorders
      • Ocrelizumab
      • Ofatumumab
      • Optic Coherence Tomography (OCT) in the Diagnosis and Management of Multiple Sclerosis
      • Oral Cladribine (Mavenclad®) for MS
      • Ozanimod
      • Pediatric-Onset Multiple Sclerosis
      • Plasmapheresis in Multiple Sclerosis
      • PML Diagnosis & Management
      • Ponesimod
      • Radiologically Isolated syndrome (RIS)
      • Relapse Management in Multiple Sclerosis
      • Safety Monitoring for Multiple Sclerosis Patients on Disease Modifying Therapies
      • Satralizumab
      • Siponimod
      • Smoking and MS: Unraveling the Links, Impact on Disease Progression, and Cessation Strategies
      • Sphingosine 1-phosphate Receptor Modulators (Comprehensive)
      • Switching Disease Modifying Therapies in Multiple Sclerosis
      • Telehealth in MS and Neuroimmunology Care
      • The Manifestations and Implications of Sexual Dysfunction in MS Patients
      • The Role of MRI in the Diagnosis and Management of MS
      • The Role of Physical Exercise in Managing Multiple Sclerosis Symptoms
      • The Role of Stem Cell Therapy in Managing Multiple Sclerosis Patients
      • The Role of Wellness Consultations in the Management of Multiple Sclerosis
      • Understanding and Addressing Vitamin D Deficiency in MS
      • Understanding and Managing Pain in Multiple Sclerosis
      • Use of Dalfampridine (Ampyra)
      • Use of DMF in MS (Tecfidera, BG-12)
      • Vaccination Recommendations for Multiple Sclerosis Patients
      • Women’s Health in Myelin Oligodendrocyte Glycoprotein Antibody Disease
      • Women’s Health in Neuromyelitis Optica Spectrum Disorder
  • Appointments 866.588.2264
  • Appointments & Locations
  • Request an Appointment
Facebook Twitter YouTube Instagram LinkedIn Pinterest Snapchat
Actions
Appointments & AccessAccepted InsuranceEvents CalendarFinancial AssistanceGive to Cleveland ClinicPay Your Bill OnlinePrice TransparencyRefer a PatientPhone DirectoryVirtual Second OpinionsVirtual Visits
Blog, News & Apps
Consult QDPrime Health GuideNewsroomMyClevelandClinicMyChart
About Cleveland Clinic
100 Years of Cleveland ClinicAbout UsLocationsQuality & Patient SafetyPatient ExperienceResearch & InnovationsCommunity CommitmentCareersFor EmployeesResources for Medical Professionals
Site Information & Policies
Send Us FeedbackSite MapAbout this WebsiteCopyright, Reprint & LicensingWebsite Terms of UsePrivacy PolicyNotice of Privacy PracticesNon-Discrimination and Availability
9500 Euclid Avenue, Cleveland, Ohio 44195 | 800.223.2273 | © 2026 Cleveland Clinic. All Rights Reserved.
Back to Top

Prime Health Guide is an editorial health information brand operated by 3PWEB SERVICOS DE INTERNET LTDA, CNPJ 05.932.717/0001-95.

Privacy Policy Terms of Use Contact Legal Disclaimer

© 2026 Prime Health Guide. All rights reserved.